Literature DB >> 10982326

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.

L Yuan1, A Geyer, D C Hodgins, Z Fan, Y Qian, K O Chang, S E Crawford, V Parreño, L A Ward, M K Estes, M E Conner, L J Saif.   

Abstract

We investigated the immunogenicity of recombinant double-layered rotavirus-like particle (2/6-VLPs) vaccines derived from simian SA11 or human (VP6) Wa and bovine RF (VP2) rotavirus strains. The 2/6-VLPs were administered to gnotobiotic pigs intranasally (i.n.) with a mutant Escherichia coli heat-labile toxin, LT-R192G (mLT), as mucosal adjuvant. Pigs were challenged with virulent Wa (P1A[8],G1) human rotavirus at postinoculation day (PID) 21 (two-dose VLP regimen) or 28 (three-dose VLP regimen). In vivo antigen-activated antibody-secreting cells (ASC) (effector B cells) and in vitro antigen-reactivated ASC (derived from memory B cells) from intestinal and systemic lymphoid tissues (duodenum, ileum, mesenteric lymph nodes [MLN], spleen, peripheral blood lymphocytes [PBL], and bone marrow lymphocytes) collected at selected times were quantitated by enzyme-linked immunospot assays. Rotavirus-specific immunoglobulin M (IgM), IgA, and IgG ASC and memory B-cell responses were detected by PID 21 or 28 in intestinal and systemic lymphoid tissues after i.n. inoculation with two or three doses of 2/6-VLPs with or without mLT. Greater mean numbers of virus-specific ASC and memory B cells in all tissues prechallenge were induced in pigs inoculated with two doses of SA11 2/6-VLPs plus mLT compared to SA11 2/6-VLPs without mLT. After challenge, anamnestic IgA and IgG ASC and memory B-cell responses were detected in intestinal lymphoid tissues of all VLP-inoculated groups, but serum virus-neutralizing antibody titers were not significantly enhanced compared to the challenged controls. Pigs inoculated with Wa-RF 2/6-VLPs (with or without mLT) developed higher anamnestic IgA and IgG ASC responses in ileum after challenge compared to pigs inoculated with SA11 2/6-VLPs (with or without mLT). Three doses of SA 11 2/6-VLP plus mLT induced the highest mean numbers of IgG memory B cells in MLN, spleen, and PBL among all groups postchallenge. However, no significant protection against diarrhea or virus shedding was evident in any of the 2/6-VLP (with or without mLT)-inoculated pigs after challenge with virulent Wa human rotavirus. These results indicate that 2/6-VLP vaccines are immunogenic in gnotobiotic pigs when inoculated i.n. and that the adjuvant mLT enhanced their immunogenicity. However, i.n. inoculation of gnotobiotic pigs with 2/6-VLPs did not confer protection against human rotavirus challenge.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982326      PMCID: PMC102078          DOI: 10.1128/jvi.74.19.8843-8853.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus.

Authors:  M M McNeal; M N Rae; R L Ward
Journal:  Vaccine       Date:  1999-03-17       Impact factor: 3.641

2.  Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice.

Authors:  S E Coffin; C A Moser; S Cohen; H F Clark; P A Offit
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Protection against rotavirus infections by DNA vaccination.

Authors:  J E Herrmann; S C Chen; E F Fynan; J C Santoro; H B Greenberg; S Wang; H L Robinson
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

4.  Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay.

Authors:  M K Slifka; R Ahmed
Journal:  J Immunol Methods       Date:  1996-11-29       Impact factor: 2.303

5.  Immune responses to individual rotavirus proteins following heterologous and homologous rotavirus infection in mice.

Authors:  S I Ishida; N Feng; J M Gilbert; B Tang; H B Greenberg
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

6.  Pathogenesis of an attenuated and a virulent strain of group A human rotavirus in neonatal gnotobiotic pigs.

Authors:  L A Ward; B I Rosen; L Yuan; L J Saif
Journal:  J Gen Virol       Date:  1996-07       Impact factor: 3.891

7.  Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge.

Authors:  P A Offit; K I Dudzik
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

8.  Active protection against rotavirus infection of mice following intraperitoneal immunization.

Authors:  M M McNeal; J F Sheridan; R L Ward
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

9.  Role of coproantibody in clinical protection of children during reinfection with rotavirus.

Authors:  B S Coulson; K Grimwood; I L Hudson; G L Barnes; R F Bishop
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

10.  PROCUREMENT AND MAINTENANCE OF GERM-FREE SEINE FOR MICROBIOLOGICAL INVESTIGATIONS.

Authors:  R C MEYER; E H BOHL; E M KOHLER
Journal:  Appl Microbiol       Date:  1964-07
View more
  29 in total

1.  Rotavirus virus-like particles as surrogates in environmental persistence and inactivation studies.

Authors:  Santiago Caballero; F Xavier Abad; Fabienne Loisy; Françoise S Le Guyader; Jean Cohen; Rosa M Pintó; Albert Bosch
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

2.  Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection.

Authors:  Janina Q Jiang; Xiao-Song He; Ningguo Feng; Harry B Greenberg
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

3.  Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.

Authors:  Audrey Glynn; Chad J Roy; Bradford S Powell; Jeffrey J Adamovicz; Lucy C Freytag; John D Clements
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus.

Authors:  M S P Azevedo; L Yuan; S Pouly; A M Gonzales; K I Jeong; T V Nguyen; L J Saif
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen.

Authors:  Trang V Nguyen; Lijuan Yuan; Marli S P Azevedo; Kwang-il Jeong; Ana M Gonzalez; Cristiana Iosef; Karin Lovgren-Bengtsson; Bror Morein; Peggy Lewis; Linda J Saif
Journal:  Clin Vaccine Immunol       Date:  2006-04

6.  Sequence analysis of the VP4, VP6, VP7, and NSP4 gene products of the bovine rotavirus WC3.

Authors:  Max Ciarlet; Joseph M Hyser; Mary K Estes
Journal:  Virus Genes       Date:  2002-03       Impact factor: 2.332

7.  Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.

Authors:  Lijuan Yuan; Ke Wen; Marli S P Azevedo; Ana M Gonzalez; Wei Zhang; Linda J Saif
Journal:  Vaccine       Date:  2008-04-18       Impact factor: 3.641

8.  Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

Authors:  A M González; T V Nguyen; M S P Azevedo; K Jeong; F Agarib; C Iosef; K Chang; K Lovgren-Bengtsson; B Morein; L J Saif
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

9.  Development of a human rotavirus induced diarrhea model in Chinese mini-pigs.

Authors:  Jin-Tao Li; Jing Wei; Hong-Xia Guo; Jiang-Bo Han; Nan Ye; Hai-Yang He; Tian-Tian Yu; Yu-Zhang Wu
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

10.  Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.

Authors:  Marli S P Azevedo; Lijuan Yuan; Cristiana Iosef; Kyeong-Ok Chang; Yunjeong Kim; Trang Van Nguyen; Linda J Saif
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.